Marker, Daniel F <br/><br/>
LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.  [electronic resource] 

 -  Journal of neuroinflammation  Nov 2012 
 - 261 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1742-2094 
<br/><br/><label>Standard No.: </label>10.1186/1742-2094-9-261  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Animals<br/>Annexin A5--pharmacology<br/>Axons--drug effects<br/>CD11b Antigen--genetics<br/>Cell Line, Transformed<br/>Coculture Techniques<br/>Cytokines--genetics<br/>Cytoplasm--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Gene Expression Regulation, Viral--drug effects<br/>HIV-1--drug effects<br/>Hippocampus--cytology<br/>Humans<br/>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2<br/>Mice<br/>Microfluidic Analytical Techniques<br/>Microglia--drug effects<br/>Microspheres<br/>Neurons--drug effects<br/>Phagocytosis--drug effects<br/>Phosphorylation--drug effects<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>RNA, Messenger--metabolism<br/>Serine--metabolism<br/>tat Gene Products, Human Immunodeficiency Virus--pharmacology